Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Moliterno

Showing results (1-10 of 169) with videos related to

Pageof 17
Sort By:
Journal of Interventional Cardiology|December 19, 2008
Advances in antiplatelet therapy for ACS and PCIDavid J Moliterno
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 21, 2011
A randomized two-by-two comparison of high-dose bolus tirofiban versus abciximab and unfractionated heparin versus bivalirudin during percutaneous coronary revascularization and stent placement: the tirofiban evaluation of novel dosing versus abciximab with clopidogrel and inhibition of thrombin (TENACITY) study trialDavid J Moliterno,
Expert Opinion on Pharmacotherapy|July 29, 2006
Clopidogrel in ST-elevation myocardial infarction patients undergoing percutaneous coronary interventionHussam Hamdalla, David J Moliterno
Journal of Thrombosis and Thrombolysis|July 30, 2005
Enoxaparin in clinical practice and clinical trials of non-ST-elevation Acute Coronary Syndrome (NSTE-ACS)Pranab Das, David J Moliterno
Current Cardiology Reports|September 24, 2013
The evolving role of cardiac troponin in the evaluation of cardiac disordersPaul Anaya, David J Moliterno
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 7, 2018
Hybrid coronary revascularization: Time for a new comparator?Naoki Misumida, David J Moliterno
Current Cardiology Reports|May 25, 2011
Beyond aspirin and clopidogrel: is there a need for additional antiplatelet therapy in ACS?Lawrence Rajan, David J Moliterno
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 1, 2021
Finding sideline benefits-Of pandemics and same-day-discharge following rotational atherectomyHussam Hawamdeh, David J Moliterno
Current Cardiology Reports|April 25, 2012
New anticoagulants in ischemic heart diseaseLawrence Rajan, David J Moliterno
Journal of the American College of Cardiology|March 20, 2003
Glycoprotein IIb/IIIa inhibition in early intent-to-stent treatment of acute coronary syndromes: EPISTENT, ADMIRAL, CADILLAC, and TARGETDavid J Moliterno, Albert W Chan
Pageof 17

Showing results (1-10 of 169) with videos related to

Sort By:
Pageof 17
Journal of Interventional Cardiology|December 19, 2008
Advances in antiplatelet therapy for ACS and PCIDavid J Moliterno
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 21, 2011
A randomized two-by-two comparison of high-dose bolus tirofiban versus abciximab and unfractionated heparin versus bivalirudin during percutaneous coronary revascularization and stent placement: the tirofiban evaluation of novel dosing versus abciximab with clopidogrel and inhibition of thrombin (TENACITY) study trialDavid J Moliterno,
Expert Opinion on Pharmacotherapy|July 29, 2006
Clopidogrel in ST-elevation myocardial infarction patients undergoing percutaneous coronary interventionHussam Hamdalla, David J Moliterno
Journal of Thrombosis and Thrombolysis|July 30, 2005
Enoxaparin in clinical practice and clinical trials of non-ST-elevation Acute Coronary Syndrome (NSTE-ACS)Pranab Das, David J Moliterno
Current Cardiology Reports|September 24, 2013
The evolving role of cardiac troponin in the evaluation of cardiac disordersPaul Anaya, David J Moliterno
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 7, 2018
Hybrid coronary revascularization: Time for a new comparator?Naoki Misumida, David J Moliterno
Current Cardiology Reports|May 25, 2011
Beyond aspirin and clopidogrel: is there a need for additional antiplatelet therapy in ACS?Lawrence Rajan, David J Moliterno
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 1, 2021
Finding sideline benefits-Of pandemics and same-day-discharge following rotational atherectomyHussam Hawamdeh, David J Moliterno
Current Cardiology Reports|April 25, 2012
New anticoagulants in ischemic heart diseaseLawrence Rajan, David J Moliterno
Journal of the American College of Cardiology|March 20, 2003
Glycoprotein IIb/IIIa inhibition in early intent-to-stent treatment of acute coronary syndromes: EPISTENT, ADMIRAL, CADILLAC, and TARGETDavid J Moliterno, Albert W Chan
Pageof 17